Stéphanie Andrade

University of Porto

H指数:19

被引数:1,579

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted liposomal epigallocatechin delivery for Alzheimer's disease: Effect on amyloid β fibrillation and neutralization of free radicals

靶向脂质体表没食子儿茶素递送用于阿尔茨海默病：对淀粉样β纤维化的影响及自由基中和

International Journal of Biological Macromolecules

IF8.5

2026-05-060

OAAI

Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease

阿尔茨海默病治疗中药物递送至脑部，跨越血脑屏障的纳米粒子递送策略进展

Pharmaceuticals

IF4.8

2026-04-270

OAAI

Lactoferrin-Decorated PLGA Nanoparticles for Targeted Tamoxifen Repurposing in Glioblastoma Cells

乳铁蛋白修饰的PLGA纳米颗粒用于靶向他莫昔芬在胶质母细胞瘤细胞中的药物重定位

Polymers

IF4.9

2026-04-270

Solid lipid nanoparticles as carriers for Ulva rigida peptide extract with demonstrated anti-β-amyloid and antioxidant properties

固体脂质纳米粒作为载体，用于具有抗β-淀粉样蛋白和抗氧化特性的孔石莼肽提取物。

Frontiers in Aging Neuroscience

IF4.5

2026-03-130

OAAI

PLGA Nanoparticles Double-Decorated with a TAT Peptide and Folic Acid to Target Staphylococcus aureus

PLGA纳米粒子双重修饰TAT肽和叶酸以靶向金黄色葡萄球菌

International Journal of Molecular Sciences 2025, Vol. 26, Page 10666

IF4.9

2025-11-010

OAAI

Mucoadhesive chitosan-modified PLGA nanoparticles loaded with green tea extract inhibit amyloid β peptide aggregation and oxidative stress

壳聚糖修饰的PLGA纳米粒负载绿茶提取物可抑制淀粉样β肽聚集和氧化应激

Journal of Molecular Liquids

IF5.2

2025-10-020

OAAI

Targeted Fluoxetine Delivery Using Folic Acid-Modified PLGA Nanoparticles for Selective Uptake by Glioblastoma Cells

靶向氟西汀递送：利用叶酸修饰的PLGA纳米粒子实现胶质母细胞瘤细胞的选择性摄取

Pharmaceutics 2025, Vol. 17, Page 1116

IF5.5

2025-08-270

OAAI

Could encapsulation of natural compounds in BBB-permeable nanocarriers produce effective Alzheimer's disease treatments?

封装在血脑屏障通透性纳米载体中的天然化合物能否产生有效的阿尔茨海默病治疗方法？

NANOMEDICINE

IF3.9

2024-12-270

PRE

Folic-Acid-Conjugated Poly (Lactic-Co-Glycolic Acid) Nanoparticles Loaded with Gallic Acid Induce Glioblastoma Cell Death by Reactive-Oxygen-Species-Induced Stress

POLYMERS

IF4.9

2024-07-300

OAAI

Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2023-05-0129

OAAI

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials

PHARMACEUTICS

IF5.5

2023-01-0723

OAAI

Transferrin-Functionalized Liposomes for the Delivery of Gallic Acid: A Therapeutic Approach for Alzheimer's Disease

PHARMACEUTICS

IF5.5

2022-10-1117

OAAI

Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer?s disease therapy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2022-10-0129

OAAI

Interaction of Bortezomib with Cell Membranes Regulates Its Toxicity and Resistance to Therapy

MEMBRANES

IF3.6

2022-08-234

OAAI

Multi-Dose Intravenous Administration of Neutral and Cationic Liposomes in Mice: An Extensive Toxicity Study

PHARMACEUTICALS

IF4.8

2022-06-1812

OAAI

The interaction of a β2 adrenoceptor agonist drug with biomimetic cell membrane models: The case of terbutaline sulphate

LIFE SCIENCES

IF5.1

2021-11-016

PRE

Caffeic acid for the prevention and treatment of Alzheimer's disease: The effect of lipid membranes on the inhibition of aggregation and disruption of Aβ fibrils

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2021-11-0125

PREAI

Influence of in vitro neuronal membranes on the anti-amyloidogenic activity of gallic acid: Implication for the therapy of Alzheimer's disease

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2021-10-0116

PRE

Liposomes as biomembrane models: Biophysical techniques for drug-membrane interaction studies

JOURNAL OF MOLECULAR LIQUIDS

IF5.2

2021-07-0148

PREAI

Vitamin B12 Inhibits Aβ Fibrillation and Disaggregates Preformed Fibrils in the Presence of Synthetic Neuronal Membranes

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-06-1612

PREAI

Stéphanie Andrade

个人简介

教育背景

工作经历

荣誉奖项

研究方向